EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

18 F‐Fallypride: A Valuable Agent for Islet Cell‐Targeted Imaging

Yangyang Qin, Xiaowei Lu, Kaiwei Xu, Ruoyu Wu, Wenqi Shen, Jiajing Ni, Jianhua Wang

Organ Medicine · 2025

DOI: 10.1002/orm2.70009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organ Medicine, 2025. Verfasst von Yangyang Qin und 6 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Islet dysfunction can lead to a wide range of digestive and endocrine disorders; therefore, the visual monitoring of islet cell function is of particular significance. We aim to evaluate the usefulness of the dopamine D2 receptor imaging agent (s)‐(−)‐ N ‐(1‐allylpyrrolidine‐2‐ N ‐methyl)‐5‐(3‐ 18 F)‐2,3‐dimethoxy‐benzamide ( 18 F‐fallypride) for islet cell‐targeted imaging.

Methods

We investigated the effect of different concentrations of the dopamine inhibitor droperidol on the binding of 18 F‐fallypride to islet cells. We calculated the cellular binding rate by incubating islet cells (1.5 × 10 4 cells/well) with 18 F‐fallypride (3.70 kBq). The rate of 18 F‐fallypride binding in six groups of islet cells treated with different concentrations of droperidol was measured, and the 18 F‐fallypride binding by the cells in relation to the inhibitor concentration was plotted. To further investigate the binding of 18 F‐fallypride to islet cells in vivo, six groups (A–F) of mice were set up. The groups were injected with 18 F‐fallypride 30 min before intravenous injection of different concentrations of droperidol. After a 10‐minute observation, the pancreas was dissected and sectioned for autoradiography. Finally, the grayscale of the pancreatic tissue was evaluated and quantified. The overall comparisons among all groups were done using single‐factor analysis of variance, and comparisons among groups were done using the least significant difference test.

Results

(1) The in vitro islet cell‐binding rate of 18 F‐fallypride was 18.4% ± 1.21%. The binding rates of the droperidol inhibition groups were 16.11% ± 1.37%, 15.76% ± 0.99%, 13.9% ± 1.02%, 8.86% ± 0.73%, 7.26% ± 0.62%, and 6.92% ± 0.58%. When the concentration of droperidol was 1.0 × 10 −4 M, the 18 F‐fallypride binding rate of islet cells was the lowest, and the inhibition rate was 51.85%. No significant difference was detected between the binding rates of the 5 × 10 −4 M and 1.0 × 10 −3 M droperidol groups ( p = 0.11 and 0.06). (2) The autoradiography showed that the pancreas grayscale of Group A (control) was 1.21 × 10 6 (DLU/mm 2 ). However, the pancreas grayscale levels of Groups B–F were 0.93 × 10 6 (DLU/mm 2 ), 0.77 × 10 6 (DLU/mm 2 ), 0.59 × 10 6 (DLU/mm 2 ), 0.32 × 10 6 (DLU/mm 2 ), and 0.25 × 10 6 (DLU/mm 2 ), respectively; namely, it decreased with increasing concentrations of the inhibitor.

Conclusion

18 F‐fallypride specifically and efficiently binds to dopamine receptors on islet cells, and therefore presents as a promising novel radiotracer for islet cells imaging.

Förderung

  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Qin, Y., Lu, X., Xu, K., Wu, R., Shen, W., Ni, J., & Wang, J. (2025). 18 F‐Fallypride: A Valuable Agent for Islet Cell‐Targeted Imaging. Organ Medicine. https://doi.org/10.1002/orm2.70009

Vancouver

Qin Y, Lu X, Xu K, Wu R, Shen W, Ni J, et al. 18 F‐Fallypride: A Valuable Agent for Islet Cell‐Targeted Imaging. Organ Medicine. 2025. doi:10.1002/orm2.70009

BibTeX
@article{Qin2025,
  author = {Qin, Yangyang and Lu, Xiaowei and Xu, Kaiwei and Wu, Ruoyu and Shen, Wenqi and Ni, Jiajing and Wang, Jianhua},
  title = {18 F‐Fallypride: A Valuable Agent for Islet Cell‐Targeted Imaging},
  journal = {Organ Medicine},
  year = {2025},
  doi = {10.1002/orm2.70009}
}
Kostenlos starten →